DarioHealth Company

DarioHealth is a digital health company. It is engaged in the development and commercialization of patented and proprietary technology that provides consumers with laboratory-testing capabilities using smartphones and other mobile devices. The company's product, Dario Blood sugar monitor is a mobile, real-time, cloud-based, diabetes management solution based on a multi-featured software application combined with a blood glucose monitoring device. The group operates internationally and derives revenues from the sale of its Dario smart meter and related device-specific disposables test strip cartridges and lancets. The company generates the majority of the revenue.
Industry: P4 Medicine
Headquarters: New York
Founded Date: 2011-01-01
Employees Number: 101-250
Funding Status: IPO
Investors Number: 10
Total Funding: $219,003,822
Estimated Revenue: $1M to $10M
Last Funding Type: Post-IPO Debt

Visit Website
info@mydario.com
https://twitter.com/DarioHealth
Register and Claim Ownership